SpyGlass Pharma SGP Cash Flow Statement (2025-2026)

NASDAQ SGP
$25.44 -0.54 (-2.08%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

SpyGlass Pharma Quarterly Cash Flow Statement

Periods 2 quarters
Latest Jun 2026

SpyGlass Pharma cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 2 quarters of results from Jun 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2025 Jun2026
Operating Activities
Net Income -8.68M-19.86M
Depreciation and Depletion 0.14M0.34M
Gains from Sales and Divestitures -0.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization 0.14M0.34M

SpyGlass Pharma Cash Flow Statement API

Pull SpyGlass Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SGP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY